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Association of muscle-specific kinase MuSK with the
acetylcholine receptor in mammalian muscle
Abstract
During synaptogenesis at the neuromuscular junction, a neurally released factor, agrin, causes the
clustering of acetylcholine receptors (AChRs) in the muscle membrane beneath the nerve terminal.
Agrin acts through a specific receptor which is thought to have a receptor tyrosine kinase, MuSK, as one
of its components. In agrin-treated muscle cells, both MuSK and the AChR become tyrosine
phosphorylated. To determine how the activation of MuSK leads to AChR clustering, we have
investigated their interaction in cultured C2 myotubes. Immunoprecipitation experiments showed that
MuSK is associated with the AChR and that this association is increased by agrin treatment. Agrin also
caused a transient activation of the AChR-associated MuSK, as demonstrated by MuSK
phosphorylation. In agrin-treated myotubes, MuSK phosphorylation increased with the same time
course as phosphorylation of the beta subunit of the AChR, but declined more quickly. Although both
herbimycin and staurosporine blocked agrin-induced AChR phosphorylation, only herbimycin inhibited
the phosphorylation of MuSK. These results suggest that although agrin increases the amount of
activated MuSK that is associated with the AChR, MuSK is not directly responsible for AChR
phosphorylation but acts through other kinases.
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ation with the AChR clusters (Wallace, 1989), suggesting
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muscle fibers (Gautam et al., 1996).
The muscle receptor for neurally released agrin has notDuring synaptogenesis at the neuromuscular junction, been fully defined, but a trk-related receptor tyrosine
a neurally released factor, agrin, causes the clustering kinase, MuSK, appears to be one of its components
of acetylcholine receptors (AChRs) in the muscle mem- (Jennings et al., 1993; Valenzuela et al., 1995). Like thebrane beneath the nerve terminal. Agrin acts through AChR, MuSK is localized in the synapse in mature
a specific receptor which is thought to have a receptor
muscles and its expression is increased extrasynapticallytyrosine kinase, MuSK, as one of its components. In following denervation (Valenzuela et al., 1995). Neural
agrin-treated muscle cells, both MuSK and the AChR
agrin induces tyrosine autophosphorylation of MuSK, andbecome tyrosine phosphorylated. To determine how
appears to bind a complex containing MuSK and one orthe activation of MuSK leads to AChR clustering, we
more muscle-specific factors (Glass et al., 1996). Mosthave investigated their interaction in cultured C2 importantly, mice in which the MuSK gene has beenmyotubes. Immunoprecipitation experiments showed disrupted have a phenotype that is similar to that seenthat MuSK is associated with the AChR and that this in agrin-deficient mice, in that the muscle fibers lackassociation is increased by agrin treatment. Agrin also differentiated synapses and nerve-associated AChR clus-caused a transient activation of the AChR-associated
ters (DeChiara et al., 1996). In addition, cultured myotubesMuSK, as demonstrated by MuSK phosphorylation.
from the MuSK–/– mice fail to cluster AChRs in responseIn agrin-treated myotubes, MuSK phosphorylation
to agrin (Glass et al., 1996). Another possible constituentincreased with the same time course as phosphorylation
of the receptor for agrin is α-dystroglycan, which is theof the β subunit of the AChR, but declined more
predominant agrin-binding protein in muscle, and whichquickly. Although both herbimycin and staurosporine
is a component of the dystrophin–utrophin glycoproteinblocked agrin-induced AChR phosphorylation, only
complex of skeletal muscle (Bowe et al., 1994; Campanelliherbimycin inhibited the phosphorylation of MuSK.
et al., 1994; Gee et al., 1994; Sugiyama et al., 1994).These results suggest that although agrin increases the
Although α-dystroglycan binds to agrin, its functional roleamount of activated MuSK that is associated with the
in agrin-mediated synaptic organization has remainedAChR, MuSK is not directly responsible for AChR
unclear (Sealock and Froehner, 1994) because it binds tophosphorylation but acts through other kinases.
active neural as well as inactive muscle isoforms of agrinKeywords: acetylcholine receptor/agrin/muscle-specific (Sugiyama et al., 1994; Bowen et al., 1996) and becausekinase MuSK/neuromuscular junction/tyrosine
short recombinant C-terminal fragments of neural agrin,phosphorylation
which do not bind to α-dystroglycan, retain significant
AChR clustering activity (Gesemann et al., 1995, 1996;
Hopf and Hoch, 1996).Introduction In addition to the activation of MuSK, agrin induces
tyrosine phosphorylation of the β subunit of the AChRDifferentiation of the synaptic apparatus at the neuro-
(Wallace et al., 1991; Qu and Huganir, 1994; Meier et al.,muscular junction occurs through the exchange of signals
1995; Ferns et al., 1996). In mammalian muscle, thisbetween nerve and muscle cells. One of the earliest signals
phosphorylation is transient, with a time course thatis the release of agrin by nerve terminals (McMahan,
precedes the time course of AChR cluster formation.1990; Reist et al., 1992). Agrin acts on a specific receptor
Although not demonstrated to be required for AChRin the muscle cell membrane to cause the clustering of
cluster formation in muscle cells, phosphorylation of theacetylcholine receptors (AChRs) beneath the nerve ter-
AChR β subunit is well correlated with the formation ofminal (Nastuk et al., 1991). Due to alternative splicing,
AChR clusters under several conditions, suggesting thatagrin exists in several isoforms that differ in AChR
it may play a critical role (Ferns et al., 1996; Meier et al.,clustering activities and tissue distribution (Ferns et al.,
1996). In support of this idea, inhibitors that block tyrosine1992; Ruegg et al., 1992). The most active forms are
phosphorylation of the AChR also block AChR clusterexpressed exclusively in neurons, whereas the predominant
formation. Thus, herbimycin, a specific inhibitor of tyro-agrin forms in muscle are much less effective in aggregat-
ing AChRs (Ferns et al., 1993; Hoch et al., 1993). In sine kinases, and staurosporine, a more general inhibitor
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of protein kinases, block both agrin-induced AChR
phosphorylation and AChR clustering (Wallace, 1994;
Ferns et al., 1996).
Agrin-induced tyrosine phosphorylation of the AChR
could, in principle, occur by several mechanisms; agrin-
activated MuSK could phosphorylate the AChR directly
or it could act through other kinases. We have previously
investigated AChR phosphorylation in mammalian muscle
by src family kinases (Fuhrer and Hall, 1996). Our
experiments showed that src binds to, and can phos-
phorylate, fusion proteins derived from the cytoplasmic
loop of the AChR β subunit; the binding region on the
β subunit contains a conserved tyrosine that is phosphoryl-
ated in the receptor isolated from the electric organ
of Torpedo (Wagner et al., 1991). Immunoprecipitation
experiments showed that muscle AChR is associated with
both src and fyn (Fuhrer and Hall, 1996), raising the
possibility that src phosphorylates the AChR, and that fyn
becomes bound as a result of this phosphorylation (Swope
and Huganir, 1993, 1994). Another route leading to AChR
phosphorylation might involve direct phosphorylation of
the β subunit by MuSK. In support of this idea, the AChR
β subunit is tyrosine phosphorylated when the AChR,
MuSK and the postsynaptic 43 kDa protein, rapsyn,
are co-expressed in transfected QT-6 quail fibroblasts
(Gillespie et al., 1996). As this phosphorylation requires
MuSK kinase activity, the β subunit of the AChR could
be a direct substrate for MuSK, as proposed by Gillespie
et al. (1996); alternatively, MuSK activation could be an
early step in the pathway leading to AChR phosphoryl-
ation. In this system, phosphorylation of the AChR
β subunit depends on co-expression of both MuSK and
rapsyn, raising the possibility that all three proteins are
Fig. 1. Association of MuSK with the AChR in C2 myotubes.part of a complex involved in AChR clustering.
(A and B) Characterization of MuSK antibodies. Extracts made fromTo clarify the relationship between MuSK and AChR
C2 myotubes or COS cells transfected with a mouse MuSK expressionphosphorylation, we have investigated the association
vector were analyzed by immunoblotting with pre-immune andbetween the two proteins in unstimulated and agrin- immune sera as indicated. (C) Co-isolation of MuSK with AChRs.
stimulated mammalian C2 muscle myotubes. We find that C2 extracts were incubated with α-bungarotoxin coupled to Sepharose
beads (TS) to isolate the AChR. As controls, 10 µM free toxin wasMuSK is associated with the AChR and that receptor-
added to compete for receptor binding to toxin–Sepharose (1T), orbound MuSK rapidly becomes tyrosine phosphorylated
non-conjugated Sepharose beads were used (CS). AChR-associated
after addition of neural agrin. Block of tyrosine phos- MuSK was analyzed by SDS–PAGE and immunoblotting with MuSK-
phorylation of the AChR β subunit by the kinase inhibitor specific antibodies. A fraction (0.3%) of the initial lysate was loaded
as a standard (L). For the lower panel, the blot was stripped andstaurosporine can be achieved without affecting MuSK
reprobed with mAb 124, which is reactive with the AChR β subunit.activation, however, suggesting that another tyrosine (D) Co-immunoprecipitation of the AChR with MuSK. C2 myotubekinase is responsible for agrin-induced phosphorylation
extracts were incubated with the indicated amounts of MuSK
of the AChR. antibodies, and the presence of AChRs in the immunoprecipitates was
assessed by non-reducing SDS–PAGE and mAb 124 immunoblotting.
Controls included a portion (0.5%) of the initial lysate (L) as well asResults an incubation of MuSK antibodies with blank lysis buffer (–lysate
sample). (E) The AChR is not associated with the transferrin receptor.MuSK is associated with the AChR in C2 Toxin–Sepharose precipitations of the AChR were analyzed by
myotubes immunoblotting using antibodies reactive with the transferrin receptor.
L represents 0.3% of the initial lysate, F the efficiency of AChRIn our initial experiments, we sought to detect interaction
recovery using toxin–Sepharose. After precipitation with toxin–beads,between MuSK and the AChR in C2 myotubes using co-
the indicated percentages of samples were analyzed by mAb 124precipitation experiments. For this purpose, we used a immunoblotting. For comparison, fractions of the initial lysate werepolyclonal antiserum raised against the C-terminus of loaded.
MuSK that specifically recognized mouse MuSK on
immunoblots (Figure 1A and B) and in immunoprecipit-
ations (see Figure 4C). As shown previously by Glass for the presence of MuSK by stripping the beads with
SDS sample buffer, separating the proteins by SDS–PAGEet al. (1996), MuSK migrated as a band, or sometimes a
doublet, with an apparent molecular weight of ~110 kDa. and immunoblotting with the MuSK-specific antibody.
The immunoblots show that MuSK was present on theTo test for its association with the AChR, we first isolated
the AChR from C2 myotube extracts with α-bungarotoxin beads (Figure 1C); its presence required the AChR, since
when AChR precipitation was prevented by the additioncovalently coupled to Sepharose beads. We then looked
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of excess α-bungarotoxin to the C2 extract prior to
incubation with the beads, no MuSK was detected. MuSK
was also not detected when unconjugated Sepharose beads
were used as a control. In each case, the presence or
absence of the AChR on the beads was confirmed by
stripping the blots and reprobing with an antibody that
recognizes the β subunit of the AChR. By comparing the
content of MuSK in AChR isolates with the content in
the initial lysate, we estimate that 0.29 6 0.02% (mean
6 SD, data from three experiments) of the total MuSK
in the cell lysates is bound to the toxin–Sepharose beads.
A similar comparison for the AChR (Figure 1F) shows
that 14.9 6 4.7% of the total AChR in C2 extracts can
be recovered on the beads. Taken together, these values
suggest that at least 2% of the total MuSK in C2 myotubes
is associated with the AChR.
Several experiments were carried out to determine
whether the co-precipitation of MuSK with the AChR
represents a specific association rather than non-specific Fig. 2. Neural agrin leads to increased association of MuSK with the
trapping of membrane proteins. First, the extent of MuSK AChR. C2 myotubes were stimulated for the indicated times with
co-precipitation using toxin–beads was constant and repro- 5 nM neural (4,8) or muscle (0,0) agrin. (A) Cell extracts were
incubated with α-bungarotoxin–Sepharose beads to isolate AChRs, andducible over several experiments. Second, the association
receptor-associated MuSK was visualized by SDS–PAGE and MuSKof MuSK with the AChR isolated on toxin–beads was not immunoblotting. In a control sample, 10 µM free toxin was added to
significantly changed by cell lysis and washing under block AChR binding to the beads (1T). To confirm that equal
stringent conditions of high salt (0.5 M NaCl) and detergent amounts of receptor are present in the appropriate lanes, the blot was
stripped and reprobed with mAb 88B, which is specific for the γ and δ(1% Triton X-100 and 0.5% deoxycholate; data not shown).
AChR subunits (lower panel). (B) Agrin-treated cells were lysed andSuch conditions resulted in the loss of other proteins such
subjected to immunoprecipitation with MuSK antiserum followed by
as β-dystroglycan (C.Fuhrer, J.E.Sugiyama and Z.W.Hall, immunoblotting with mAb 124. As controls, we omitted MuSK
unpublished observations), a membrane component of the antibodies (–ab) or the lysate (–L). We also analyzed a fraction (0.3%
dystrophin–utrophin glycoprotein complex that is found in A, 0.1% in B) of the total C2 cellular extracts as a standard (L).
(C) Quantitation of the effect of neural agrin on the amount of AChR-at synapses (Matsumura et al., 1992). Third, as a measure
associated MuSK. Experiments as described in (A) were quantitatedof non-specific binding of membrane proteins, we analyzed by densitometric scanning of films, and values of untreated cells werepreparations of AChRs isolated by toxin–beads for the set to 100%. Data represent mean 6 SD of four experiments. * Differs
presence of the transferrin receptor, a prominent membrane significantly from control, P ,0.01 (by ANOVA followed by
Bonferroni’s t-test).protein found at the plasma membrane and in endosomal
compartments (Ralston and Ploug, 1996). In an immuno-
blot analysis with specific monoclonal antibodies, no shown by both α-bungarotoxin–Sepharose precipitation
followed by MuSK immunoblotting and by MuSKdetectable transferrin receptor was seen in AChR precipit-
ates (Figure 1E). Finally, we tested for association of immunoprecipitation followed by AChR Western blotting,
agrin increases the interaction between MuSK and theMuSK with the AChR by immunoprecipitating MuSK
and looking for the presence of the AChR by immuno- AChR (Figure 2A and B). This effect is specific for neural,
but not muscle, agrin and is seen after a 16 h treatment;blotting with the antiserum against the AChR β subunit.
Although some non-specific binding to protein A– quantitation shows that the increase is ~2.5-fold and is
highly significant (Figure 2C). Agrin’s effects were mostSepharose occurred, the AChR was clearly detected in the
MuSK immunoprecipitates (Figure 1D). Taken together, pronounced at a concentration of 5 nM; we observed
smaller changes at lower amounts (0.2 nM; data notwe believe that association of MuSK with the AChR is
specific and that the two proteins form a stable complex shown). In control experiments, the amounts of AChRs
were the same in all lanes; hence agrin did not affect thewhich excludes other membrane proteins.
level of the AChRs in C2 cells (Figure 2A, bottom; see
also Jones et al., 1996).Agrin increases the association between MuSK
and the AChR
We then used the co-precipitation assays to examine the Agrin-induced activation of AChR-associated
MuSK correlates with phosphorylation of theeffects of agrin on the association of MuSK with the
AChR. C2 myotubes were incubated for increasing times AChR β subunit
To determine whether AChR-associated MuSK is activatedwith 5 nM of the soluble C-terminal fragment of either the
most active, neural-specific (C-Ag12,4,8) or the predominant by agrin, we treated C2 myotubes for increasing times
with 0.1 nM neural or muscle agrin. AChRs were thenmuscle (C-Ag12,0,0) isoform of agrin (Ferns et al., 1993).
We examined the association of MuSK and the AChR at isolated with α-bungarotoxin–Sepharose beads and the
associated proteins examined by immunoblotting withthree times after the beginning of the treatment: 40 and
90 min, when agrin-induced tyrosine phosphorylation of phosphotyrosine-specific antibodies (Figure 3). After
15 min of treatment with neural agrin, a doublet ofthe AChR β subunit is near its peak, but few clusters are
seen, and 16 h, when AChR phosphorylation has declined, immunoreactive bands was detected that migrated at
~110 kDa. Immunoreactivity remained elevated at 40 andbut cluster formation is maximal (Ferns et al., 1996). As
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Fig. 3. Neural agrin causes a rapid and transient activation of AChR-
associated MuSK. Cells were treated for increasing times with 0.1 nM
neural (4,8) or muscle (0,0) agrin. AChRs were isolated with
α-bungarotoxin–Sepharose precipitation and activation of associated
MuSK was visualized by phosphotyrosine immunoblotting. A doublet
of bands with the same molecular weight as MuSK (~110 kDa)
becomes transiently tyrosine phosphorylated, with a peak at ~40 min.
Controls included addition of 10 µM free toxin (1T) and the use of
non-conjugated control Sepharose (CS). The identity of the ~110 kDa
doublet (MuSK) was confirmed by stripping and reprobing the blot
with MuSK antibodies (lower panel).
90 min but, after 5 and 15 h, the tyrosine-phosphorylated
bands were no longer detected. By stripping and reprobing
the blot with MuSK-specific antibodies, we identified
this doublet as AChR-associated MuSK. Phosphotyrosine-
immunoreactive bands were not observed when free excess
toxin was added to the C2 extracts prior to AChR isolation,
when unconjugated Sepharose was used or when the cells Fig. 4. Dose dependence and time course of agrin-induced MuSK
were treated with muscle agrin. activation and AChR β subunit phosphorylation. (A and B) C2
We then used this system to compare three phosphoryl- myotubes were treated for increasing times with the indicated
concentrations of neural or muscle agrin. After lysis, cell extracts wereation events induced by agrin: activation of the total
split into two parts; the first was incubated with α-bungarotoxin–cellular pool of MuSK, activation of AChR-associated
Sepharose beads to isolate AChRs (top and middle panels), whereasMuSK and phosphorylation of the AChR β subunit. the second part was subjected to immunoprecipitation with MuSK-For these experiments, C2 myotubes were treated for specific antibodies (bottom panels). Both precipitates were analyzed by
increasing times with a range of neural and muscle agrin SDS–PAGE and phosphotyrosine immunoblotting. Protein bands were
identified by their molecular weight and by stripping and reprobingconcentrations. Cell extracts were then split into two parts;
blots with the appropriate antisera (not shown). Agrin-inducedone part was incubated with α-bungarotoxin–Sepharose phosphorylation of AChR-associated MuSK, AChR β subunits and ofbeads to isolate AChRs, whereas the other part was the total cellular pool of MuSK correlate over a wide range of agrin
subjected to immunoprecipitation with MuSK-specific concentrations. (C) Controls for the specificity of MuSK
immunoprecipitation. Cells were stimulated for 15 min with 15 nM ofantibodies. Both precipitations were analyzed by phospho-
neural agrin. Lysates were subjected to immunoprecipitation withtyrosine immunoblotting. We first examined the agrin
pre-immune or immune anti-MuSK sera with or without the additionconcentration dependence of the phosphorylations. As
of an excess (2.5 mg/ml) of free immunizing MuSK peptide. Samples
shown in Figure 4A, 5 nM of neural agrin caused were analyzed by phosphotyrosine immunoblotting.
phosphorylation of AChR-associated MuSK, of the AChR
β subunit and of total MuSK within as little as 5 min,
whereas in each case muscle agrin had no effect. At lower still visible after 15 h. We noted a difference in the time
course of MuSK activation at 5 nM as compared withconcentrations of agrin, all three phosphorylation events
were visible after 40 min, but not after 5 min, of treatment. 0.1 nM agrin: the high concentration induced a rapid
activation of MuSK within 5 min, whereas at the lowA slight reduction at that time in the extent of phosphoryl-
ation of AChR-bound MuSK was accompanied by concentration, activation occurred with slower kinetics, as
it was only detected after 15 min and reached a peak afterdecreased phosphorylation of both the AChR β subunit
and total MuSK. Finally, at the lowest concentration of 40 min. Control experiments confirmed the specificity of
immunoprecipitation with MuSK antibodies; thus no agrin-agrin tested, none of the three phosphorylation events was
detected. We then performed a time course of agrin induced tyrosine phosphorylation of MuSK was seen when
using the pre-immune serum or when adding an excesstreatment, using two concentrations of neural agrin.
Activation of both AChR-associated MuSK and of total of free MuSK C-terminal immunizing peptide to MuSK
immunoprecipitations (Figure 4C). In summary, theMuSK was maximal after 40 min of treatment with 5 or
0.1 nM neural agrin, and decreased to close to background phosphorylation events induced by agrin are correlated:
phosphorylation of AChR-associated MuSK shows alevels after a 15 h incubation (Figure 4B). In contrast,
phosphorylation of the AChR β subunit followed a similar similar dependence on agrin concentration and initial time
course as does phosphorylation of total MuSK and of theinitial time course, but showed a slower decline and was
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Fig. 5. Effects of herbimycin and staurosporine on agrin-induced
phosphorylation of MuSK and the AChR β subunit. C2 myotubes
were pre-treated for 6 h with 1 µM herbimycin (H), 10 nM
staurosporine (S) or a DMSO carrier control (c). Cells were then
incubated with the indicated amounts of agrin for 5 or 40 min, and
cells extracts were analyzed by precipitation with α-bungarotoxin–
Sepharose beads followed by phosphotyrosine immunoblotting (top
and middle). In some cases, parallel dishes of C2 myotubes were
treated with agrin (5 and 40 min with 1 and 0.1 nM of agrin,
respectively), and analyzed by precipitation with MuSK antibodies
followed by phosphotyrosine immunoblotting (bottom). Herbimycin
blocks all phosphorylation events, whereas staurosporine leaves MuSK
activation intact, but strongly reduces AChR β subunit
phosphorylation.
AChR; dephosphorylation of both total and AChR-bound
MuSK, however, occurs more rapidly than that of the
AChR.
Staurosporine blocks agrin-induced AChR β
Fig. 6. Staurosporine does not interfere with agrin-induced MuSKsubunit phosphorylation, but not activation of
activation, but blocks agrin-induced phosphorylation of the AChR βAChR-associated MuSK
subunit. (A) Myotubes were pre-incubated for 5 h with the indicatedTo investigate further the relationship between MuSK
concentrations of staurosporine or a carrier control (c) and then
activation and AChR phosphorylation, we used the tyrosine stimulated for 40 min with 1 nM neural agrin. Lysates were processed
kinase inhibitors, herbimycin and staurosporine, that were by α-bungarotoxin–Sepharose or MuSK antibody precipitation and
analyzed by phosphotyrosine immunoblotting. Increasing theshown previously to block agrin-induced AChR clustering
concentration of staurosporine up to 20 nM progressively reducesand tyrosine phosphorylation of the AChR β subunit
agrin-induced AChR β subunit phosphorylation without substantially(Wallace, 1994; Ferns et al., 1996). C2 myotubes were altering MuSK phosphorylation. (B) Quantitation of staurosporine’s
incubated with either 1 µM herbimycin or 10 nM stauro- effects by densitometric scanning. Data from four experiments as
described in (A) were evaluated and are shown as mean 6 SD.sporine for 6 h before adding agrin, conditions that have
Phosphorylation signals from cells not treated with agrin were set tobeen shown to be optimal for inhibition of AChR clustering
0%. Agrin-induced control signals of cells incubated with carrier,and phosphorylation. Cell extracts were then prepared lacking staurosporine, were set to 100%. All phosphorylation signals
and subjected to α-bungarotoxin–Sepharose or MuSK were normalized for the AChR contents of cells as visualized by
immunoprecipitation followed by phosphotyrosine reprobing blots containing toxin precipitates with mAb 88B.
immunoblotting. Under all conditions tested, herbimycin
blocked activation of both AChR-bound and total MuSK
as well as phosphorylation of AChR β subunits. In contrast, phosphorylate the AChR β subunit. As we have reported
previously that src can phosphorylate the AChR, and thatstaurosporine had no effect on agrin-induced activation of
MuSK, either for the total pool or for that associated with AChRs isolated from C2 myotubes are associated with
src-related kinases, we examined the effects of agrin onthe AChR, but strongly decreased phosphorylation of the
β subunit of the AChR, as previously reported (Figure 5). association of fyn and src with the AChR. As shown in
Figure 7, treatment of cells with 2.5 nM of neural agrinWhen cells were treated with increasing concentrations of
staurosporine, ranging from 1 to 20 nM, agrin-stimulated did not change the relative amounts of either kinase bound
to the AChR. In addition, neural agrin (0.1 or 2.5 nM)phosphorylation of the AChR β subunit was progressively
inhibited, but no effect was seen on activation of MuSK did not affect the overall level of tyrosine phosphorylation
of src and fyn, as measured by kinase immunoprecipitation(Figure 6). Most dramatically, at 20 nM of staurosporine,
agrin-induced AChR phosphorylation was completely using specific antibodies, followed by phosphotyrosine
immunoblotting.abolished, whereas activation of neither total nor AChR-
bound MuSK was significantly altered. These experiments
show that staurosporine does not affect agrin-induced DiscussionMuSK activation, but blocks phosphorylation of the β
subunit of the AChR caused by agrin. We have thus found The principal result of this work is the demonstration that
MuSK, the receptor tyrosine kinase that is thought toconditions that uncouple activation of MuSK from AChR
phosphorylation, suggesting that MuSK does not directly mediate the effects of agrin in clustering AChRs in muscle
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Fig. 7. Agrin does not change the amount of fyn and src associated
with the AChR, nor does it affect the overall phosphotyrosine level of
total src and fyn. (A) C2 myotubes were incubated for up to 15 h with
2.5 nM of neural agrin. Cell lysates were analyzed by precipitation
with α-bungarotoxin–Sepharose beads and immunoblotting with
antibodies specific for fyn or src; 0.1% of the total lysate was included
as a control (L). (B) C2 cells treated with neural or muscle agrin as
indicated were subjected to immunoprecipitation with fyn- or src-
specific antibodies followed by phosphotyrosine immunoblotting. Over
the course of several experiments, the signals shown in (A) and (B)
displayed some variation; however, no significant agrin effect was
seen. The figure shows one representative experiment for each
treatment (A and B).
cells, is closely associated with the AChR in C2 myotubes, Fig. 8. Tentative model of proteins interacting with the AChR in
mammalian muscle. Arrows indicate putative steps in agrin’s signalingeven in the absence of neural agrin. Treatment of the
pathway. For details, see text.myotubes with agrin results in tyrosine phosphorylation
of the AChR-associated MuSK in a manner that is similar
to agrin-induced tyrosine phosphorylation of the AChR β closely associated with the AChR in an ~1:1 stochiometry
in Torpedo synaptic membranes and muscle cellssubunit. MuSK is unlikely to be directly responsible for
phosphorylation of the AChR, however, as staurosporine, (LaRochelle and Froehner, 1986, 1987). Rapsyn is essen-
tial both for AChR aggregation in vitro and for properwhich blocks agrin-induced phosphorylation of the β
subunit, does not affect MuSK activation. These results synapse formation and AChR clustering in vivo (Froehner
et al., 1990; Phillips et al., 1991; Gautam et al., 1995). Itsuggest that phosphorylation of the AChR is mediated by
a kinase that is downstream from MuSK, and is possibly can be cross-linked to the AChR in Torpedo membranes
(Burden et al., 1983), and apparently can interact withsrc or fyn (Fuhrer and Hall, 1996).
each of the AChR subunits (Maimone and Merlie, 1993;
Yu and Hall, 1994). In preliminary experiments, we haveAssociation of MuSK with the AChR
A portion of the total pool of MuSK in C2 myotubes is found that rapsyn and the AChR can be co-precipitated
together from extracts of muscle cells (C.Fuhrer andassociated with the AChR. As judged by several criteria,
this association appears to be highly specific. For example, Z.W.Hall, unpublished observations). When co-expressed
in heterologous quail QT-6 fibroblasts, rapsyn regulatesapart from other controls, the transferrin receptor, a
prominent component of the surface membrane and of tyrosine phosphorylation of proteins that are localized at
clusters of AChRs (Qu et al., 1996). Furthermore, in thisendocytic compartments (Ralston and Ploug, 1996), is not
co-precipitated with the AChR. The continued association expression system, rapsyn clusters and activates MuSK,
which leads to phosphorylation on tyrosine residues ofof MuSK, but not β-dystroglycan, with the AChR under
conditions of higher stringency (C.Fuhrer, J.E.Sugiyama many cellular proteins, including AChRs (Gillespie et al.,
1996). Although further experiments will be required toand Z.W.Hall, unpublished observations) further suggests
that the interaction is specific and excludes other proteins, establish that all three components are present in the same
complex, and to determine the nature of their specificeven transmembrane proteins that are concentrated in the
postsynaptic membrane (Matsumura et al., 1992). Our interactions, MuSK could, in principle, interact with either
the AChR, or rapsyn or both (Figure 8). Interestingly, acalculation that ~2% of the total MuSK can be co-isolated
with the total AChR is likely to be a minimal estimate of recent report by Apel et al. (1997) shows that rapsyn-
induced clustering of MuSK in transfected fibroblasts thatthis association, as all MuSK–AChR complexes may not
survive extraction; the percentage of MuSK associated also express AChRs is mediated by the ectodomain of
MuSK, suggesting the existence of a transmembranewith the AChR in intact C2 myotubes may thus be
substantially higher than 2%. intermediate between the two proteins. In combination
with these observations, our data suggest that the AChROur experiments do not demonstrate a direct interaction
between MuSK and the AChR; thus the two proteins itself could be such a link between MuSK and rapsyn.
Alternatively, other proteins may be part of the complexcould be associated through one or more additional com-
ponents. A protein that is likely to be part of the AChR– containing MuSK and the AChR, and MuSK could interact
with them. Both src and fyn, for example, are associatedMuSK complex is rapsyn, the 43 kDa protein that is
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with the AChR in C2 myotubes (Fuhrer and Hall, 1996). that MuSK, both in the absence of neural agrin and
after agrin treatment, is associated preferentially withOur experiments also imply that different regulatory
mechanisms underly clustering of AChRs in transfected aggregated AChRs. In any case, as agrin causes additional
muscle proteins such as rapsyn or acetylcholinesterase tofibroblasts as opposed to myotubes (see also Qu et al.,
1996). In fibroblasts, both activation of MuSK and AChR accumulate in AChR aggregates (Wallace, 1989), MuSK
may interact with other proteins and provide a structuralclustering are induced by co-expression of rapsyn
(Gillespie et al., 1996); in muscle cells, despite the link between the AChR and other components of the
postsynaptic apparatus. In agreement with this notion,presence of all three proteins, neither of these processes
occurs efficiently, unless neural agrin is added. Myotubes Apel et al. (1997) have suggested that rapsyn may interact
with MuSK in multiple ways and that this complex couldthus appear to contain additional regulatory pathways that
link both MuSK activation and AChR aggregation to agrin. play both structural and signaling roles in agrin-induced
specialization of the neuromuscular junction. By linking
together postsynaptic proteins, AChR-bound MuSK mayAgrin-induced activation of AChR-associated
MuSK thus play a role in maintaining AChR clusters similar to
that of focal adhesion kinase (FAK) in integrin signalingAChR-associated MuSK becomes phosphorylated in
response to agrin, and this activation occurs in the same at focal adhesion sites (Clark and Brugge, 1995).
manner as activation of the total pool of MuSK. These
results confirm and extend the previous observation (Glass MuSK activation and phosphorylation of the
β subunit of the AChRet al., 1996) that high concentrations (nanomolar range)
of recombinant soluble agrin cause a rapid activation of Agrin causes tyrosine phosphorylation of the β subunit of
the AChR (Wallace et al., 1991; Qu and Huganir, 1994;MuSK. In addition, we have found that concentrations of
agrin as low as 20 pM also activate MuSK, but with Meier et al., 1995; Ferns et al., 1996); although the
conserved tyrosine phosphorylation site of this subunit issubstantially slower kinetics. These findings contrast with
those seen for other receptor tyrosine kinases. The trkA not necessary for rapsyn-induced AChR clustering in
heterologous cells (Yu and Hall, 1994; Qu et al., 1996),receptor, for example, shows maximal activation after
5 min, with a marked decline after only 15 min of the available evidence suggests that tyrosine phosphoryl-
ation of the AChR β subunit could be important fortreatment with nerve growth factor (NGF) (Kaplan et al.,
1991). The slow activation of MuSK could reflect complex receptor aggregation in muscle cells. Our experiments
reveal that the agrin-induced phosphorylation of MuSK,interactions of agrin with a multi-component receptor.
Alternatively, the delay may originate from the initial both total and AChR-associated, and of the AChR β
subunit are closely correlated and occur with the samebinding of agrin to heparin-containing components of the
extracellular matrix or to α-dystroglycan, a prominent initial time course. The duration of the phosphorylation
is different in the two cases, however, as phosphorylationagrin-binding protein of muscle cells (Bowe et al., 1994;
Campanelli et al., 1994; Gee et al., 1994; Sugiyama et al., of the β subunit lasts longer than MuSK activation. The
difference in stability of the phosphorylated state may1994). Once bound to such proteins, agrin may then be
presented to its functional receptor, including MuSK, and reflect the action of different phosphatases in the two
cases. Phosphatase-mediated dephosphorylation of thestart its signaling cascade. The activation of MuSK is
transient, even in the continued presence of agrin; MuSK AChR has been demonstrated in Torpedo electric organ
(Mei and Huganir, 1991) and has been inferred fromphosphorylation thus precedes AChR cluster formation by
several hours (Wallace, 1992; Ferns et al., 1996), even at the action of phosphatase inhibitors in chick muscle
(Wallace, 1995).the lowest concentrations of agrin. This time course is
consistent with the postulated role of MuSK early in the The similarity in time course of agrin-induced phos-
phorylation of the two proteins suggests that activatedsignaling pathway of agrin.
In addition to activating MuSK, agrin also increases MuSK could be directly responsible for phosphorylation
of the AChR, as has been proposed previously (Gillespiethe association of MuSK with the AChR, but with a time
course that is significantly slower than MuSK activation et al., 1996). However, our experiments on the effect of
staurosporine on phosphorylation of the two proteinsand that is similar to the time course of AChR clustering.
Our calculations show that this observed increase is suggests that this is not the case. Concentrations of
staurosporine that completely blocked agrin-induced~2.5-fold; as not all of the newly formed AChR–MuSK
complexes may withstand our extraction procedure, how- phosphorylation of the AChR β subunit failed to block
the activation of MuSK, as measured by tyrosine phos-ever, this increase may only be an indication of a more
prominent agrin-induced association between the two phorylation. Although we did not measure MuSK activ-
ation directly, experiments in other systems suggest thatproteins occurring in intact myotubes. Since MuSK
phosphorylation is transient, the protein that becomes activation of receptor tyrosine kinases requires tyrosine
phosphorylation. Indeed, according to the currentlyassociated with the receptor after agrin treatment is pre-
sumably not tyrosine phosphorylated, and therefore not accepted general model, receptor tyrosine kinases (RTKs)
are activated by a mechanism in which the ligand inducesactivated. The significance of this increased association is
unknown. The effect is specific for neural agrin and receptor dimerization and a trans-phosphorylation of one
dimeric partner by the other (Schlessinger and Ullrich,presumably reflects an accumulation of MuSK in AChR
clusters, similar to the localization of MuSK at the 1992; Heldin, 1995). With respect to the inhibitor, kinase
inhibition by staurosporine is not completely understood,neuromuscular junction in vivo (Valenzuela et al., 1995).
In untreated C2 myotubes, a small number of spontaneous but appears to occur by a mechanism other than competi-
tion with the phosphoacceptor substrate (Ruegg andAChR clusters are usually observed; it is therefore possible
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Burgess, 1989; Ward and O’Brian, 1992; Meggio et al., complexed to AChRs not associated with MuSK, and
become activated by other complexes containing AChR-1995). In addition, staurosporine has been shown to
inhibit both ligand-induced RTK autophosphorylation and bound MuSK. In any case, activation of MuSK that is
associated with the AChR is likely to be crucial for AChRphosphorylation of direct substrates in several signaling
systems. Examples include the insulin receptor and its cluster formation. The protein interactions regulated by
subsequent tyrosine phosphorylation might then be thesubstrate IRS-1 (Nishimura and Simpson, 1994), and the
trkA receptor for NGF and its substrate phospholipase initial steps in assembly of a specific postsynaptic complex
that concentrates AChRs under the nerve terminal andC-γ1 (Vetter et al., 1991; Ohmichi et al., 1992). Thus, our
observation that staurosporine selectively inhibits agrin- stabilizes them by association with the cytoskeleton.
induced tyrosine phosphorylation of the AChR β subunit,
but leaves autophosphorylation of MuSK intact, strongly Materials and methodsimplies that the β subunit is not a direct substrate for
activated MuSK. Cell culture
Cell culture reagents were purchased from Gibco BRL. All cell linesAs MuSK is required for synapse formation in vivo and
were grown at 37°C in 8% CO2. COS cells were maintained in Dulbecco’sfor agrin-induced AChR clustering in cultured myotubes
modified Eagle’s medium (DMEM) with 4.5 g/l D-glucose, 10% fetal(DeChiara et al., 1996; Glass et al., 1996), the differential bovine serum, 2 mM glutamine and penicillin/streptomycin. C2C12
inhibitory effects of herbimycin and staurosporine suggest mouse muscle cells were propagated as myoblasts on 10 or 15 cm plastic
dishes (Nunc) in DMEM supplemented with 20% fetal bovine serum,that it acts early in the pathway, upstream of the events
0.5% chick embryo extract, 2 mM glutamine and penicillin/streptomycin.leading to AChR phosphorylation. MuSK activation, by
After reaching 90% confluence, cells were shifted to fusion mediumitself, appears not to be sufficient to produce AChR
containing DMEM, 5% horse serum and 2 mM glutamine. Fusion of
clusters, as staurosporine leaves agrin-induced MuSK myoblasts to generate myotubes was evident after 1 day. By day 2,
activation intact, but blocks receptor clustering (Ferns contracting myotubes were usually observed, and cells were used for
experiments.et al., 1996). Further intracellular signaling steps, down-
stream of MuSK, thus seem to be necessary to cause
Expression of agrin constructsAChR aggregation, and such steps might involve phos- To obtain soluble forms of agrin, the COOH-terminal half of agrin
phorylation of the AChR itself and/or phosphorylation of isoforms was expressed in transfected COS cells. Expression constructs
encoding the most active, neural-specific isoform (C-Ag12,4,8) or theadditional muscle proteins. Apart from inhibiting serine
predominant muscle isoform (C-Ag12,0,0; Ferns et al., 1993) wereand threonine kinases as well as some RTKs, staurosporine,
transiently expressed in COS cells by using an adenovirus-mediatedsimilarly to herbimycin, is a potent inhibitor of cytosolic DEAE–dextran method of transfection (Forsayeth and Garcia, 1994).
tyrosine kinases including members of the src family After transfection, the medium was collected and replaced every day,(Uehara et al., 1989; Meggio et al., 1995). Thus, although for 3 days. The concentration of agrin in the medium was determined
by immunoblotting using an agrin-specific antiserum and purified agrinnot directly responsible for agrin-induced AChR phos-
of known concentration as a standard (Sugiyama et al., 1994; Bowenphorylation, MuSK could activate one or more inter-
et al., 1996).
mediate kinases in the agrin signaling pathway. Using
co-precipitation and GST fusion proteins, we have found Preparation of mouse MuSK expression vector
First strand cDNA was synthesized from C2 mouse muscle total RNApreviously that src is a major kinase responsible for
using Superscript reverse transcriptase with oligo(dT) as the primer, asphosphorylation of the AChR β subunit and that AChRs
directed by the manufacturer (Gibco BRL). We obtained the codingare associated with both src and fyn in C2 myotubes
region of mouse MuSK (–1 to 12607) by PCR amplification of C2 first(Fuhrer and Hall, 1996). Our experiments reported here strand cDNA using 59-GGA ATT CAC CAT GAG AGA GCT CGT
reveal neither a change in the association of src and fyn CAA CAT TCC-39 as the forward primer and 59-GCT CTA GAT TAG
ACA CCC ACC GTT CCC TCT G-39 as the reverse primer. Thewith the AChR nor a change in the overall tyrosine
resulting DNA fragment was digested with EcoRI and XbaI, and clonedphosphorylation state of the kinases due to agrin. However,
into the mammalian expression vector, pMT23 (a gift of the Genetics
as only a minor fraction of the total cellular content of Institute, Cambridge, MA), for expression in COS cells.
src and fyn is found in association with AChRs, agrin
may very well cause an activation of those kinases that Antibodies
The rabbit antiserum recognizing MuSK was made against a peptideare bound to the AChR. As src-related kinases are subject
corresponding to the C-terminal 20 amino acids of rat MuSK and wasto activating as well as inactivating tyrosine phosphoryl- produced commercially by Research Genetics. We performed several
ations (Cooper and Howell, 1993), such an activation specificity tests with this antiserum, such as immunoblotting with pre-
may not be detected by conventional phosphotyrosine immune serum (Figure 1A) and immunoprecipitations with an excess of
free MuSK immunizing peptide (Figure 4C). To ascertain that theimmunoblotting. In addition, as is the case in cellular
antibody recognizes mouse MuSK, the expression vector describedadhesion of fibroblasts, src-related kinases might also play
above was transfected into COS cells, which were then analyzed by
roles in agrin’s signaling pathway that are independent of immunoblotting (Figure 1B). In all cases, MuSK was detected as a band,
their kinase activity but require their SH2 and SH3 or sometimes a doublet, of ~110 kDa. Although useful for Western
blotting and immunoprecipitation, the MuSK antibody did not staindomains (Kaplan et al., 1995).
MuSK in immunofluorescence experiments, neither at the neuromuscularThus, the findings reported in this study, coupled with junction of tissue sections prepared from adult rats, nor in agrin-treatedthose reported earlier, suggest a model in which agrin C2 myotubes. The rat monoclonal antibody against the AChR βbinds to a receptor complex containing MuSK and other subunit, mAb 124, was a kind gift from Dr J.Lindstrom (University of
components, including the AChR, src and fyn (Figure 8). Pennsylvania, Philadelphia, PA), and the mouse monoclonal antiserum,
mAb 88B, reactive with the AChR γ and δ subunits, was generouslyBinding of agrin to the complex activates MuSK, which
provided by Dr S.C.Froehner (University of North Carolina, Chapelthen activates src and/or fyn, resulting in phosphorylation
Hill, NC). A rat monoclonal antiserum recognizing the mouse transferrin
of the β subunit of AChRs and possibly other proteins.
receptor, RI7 217 (Lesley et al., 1989), was a generous gift from Dr
Additionally, as we have no evidence for whether all J.Lesley (The Salk Institute, San Diego, CA). For phosphotyrosine
immunoblotting, we used a mixture of two commercially availableproteins are part of a single complex, src or fyn might be
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mouse monoclonal antibodies, 4G10 (Upstate Biotech.) and PY20 Acknowledgements
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